BRAF
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
July, 2024
July 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Jun
BRAF
Jun 25, 2024, 07:47 |
Blog
Mark Lewis: It is UNACCEPTABLE to treat mCRC without knowing these biomarker
Mark Lewis shared a post by FDA Oncology on X, adding the following: . “We…
May 25, 2024, 11:59 |
Blog
Vivek Subbiah: ASCO 24 time to learn the latest and greatest in Tissue Agnostic Precision Medicine
Vivek Subbiah shared on X: “It's ASCO 24 time Mark your calendars to learn the latest…
May 2, 2024, 12:13 |
Insight
New Paper Alert! BRAF Isoforms and Resistance to MAPK Inhibitors in Melanoma
BRAF Isoforms and Resistance to MAPK Inhibitors in Melanoma Authors: Francisco Aya, Pablo Lanuza-Gracia, Abel…
Mar 16, 2024, 15:39 |
Blog
Sarah Sammons: DPYD testing is required before our pharmacy will dispense capecitabine
Sarah Sammons, Breast Medical Oncologist at Dana-Farber’s Breast Oncology Center, shared a post by Vivek Subbiah…
Mar 8, 2024, 15:14 |
Blog
Vivek Subbiah: Harnessing the potential of basket trials
Vivek Subbiah recently shared a post on X/Twitter: "Revolutionizing cancer drug development: Harnessing the potential…
Feb 25, 2024, 15:01 |
Insight
Arndt Vogel: Impressive and comprehensive review on BRAF mutations
Arndt Vogel shared on X/Twitter: "BRAF — a tumor-agnostic drug target with lineage-specific dependencies. Impressive…
Dec 4, 2023, 15:54 |
Blog
Vivek Subbiah: Tissue-agnostic precision medicine takes the spotlight!
Vivek Subbiah shared a post on his LinkedIn page: "Hot off the press- Friday Motivation!…
Oct 18, 2023, 16:54 |
Drugs
Vivek Subbiah: Final efficacy and safety results of the ROAR phase 2 basket trial of dabrafenib in eight cohorts of patients with BRAFV600E-mutated advanced rare cancers
Vivek Subbiah, Chief of Early-Phase Drug Development at the Sarah Cannon Research Institute, shared on…
All:
8
Posts:
1 - 100
The largest philanthropic partnership in The V Foundation’s history - Dolphins Cancer Challenge
Glecirasib: A Promising Novel KRAS G12C Inhibitor in Clinical Development
How the Médecins Sans Frontières Journal Inspired a Lifetime of Humanitarian Service: Paul Spiegel
OncoDaily Party and Yvonne Award Photos - Part 1
Michael Douglas: The Untold Story of His Battle Against Cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube